Boothbay Fund Management’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
Other funds holding RXST
NSGL
VCM
Boothbay Fund Management's RXST Position: Q1 2026 in Review
Boothbay Fund Management sold out of RxSight (RXST) in Q1 2026, closing a stake of 11,797 shares — an estimated $123K sold.
Boothbay Fund Management first reported a position in RXST in Q3 2021 and held it in 8 quarters. The position peaked at $674K in Q3 2021. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.
- Boothbay Fund Management reported no remaining RxSight position as of Q1 2026 after selling out during the quarter.
- Boothbay Fund Management sold 11,797 RxSight shares in Q1 2026, an estimated $123K.
- Boothbay Fund Management first reported a position in RxSight in Q3 2021 and held it in 8 quarters.
- Boothbay Fund Management's RxSight position peaked at $674K in Q3 2021.
- 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.
Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.